Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01077258
Other study ID # P10-448
Secondary ID
Status Completed
Phase N/A
First received February 25, 2010
Last updated April 9, 2014
Start date April 2004
Est. completion date February 2013

Study information

Verified date April 2014
Source AbbVie
Contact n/a
Is FDA regulated No
Health authority Germany: Paul-Ehrlich-Institut
Study type Observational

Clinical Trial Summary

Observation of safety, tolerability and effectiveness of adalimumab (Humira) therapy in a large patient collective under everyday clinical conditions over 2 years.


Description:

Patients with rheumatoid arthritis who started treatment with adalimumab in a normal clinical setting according to the product label were documented. The follow-up observation period was for 2 years and focused on safety information and maintenance of efficacy during a normal clinical setting. Follow-up with participants was via regular office visits at intervals as determined by routine clinical practice or as recommended by national guidelines.


Recruitment information / eligibility

Status Completed
Enrollment 4208
Est. completion date February 2013
Est. primary completion date February 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Moderate to severe active rheumatoid arthritis in adults with insufficient response to disease-modifying antirheumatic drugs, including methotrexate

- Moderate to severe active rheumatoid arthritis in adults who have not been treated with methotrexate before. In case of incompatibility with methotrexate, Humira can be used as monotherapy

Exclusion Criteria:

- Hypersensitivity against the drug or one of the other ingredients

- Active tuberculosis or other severe infections (e.g. sepsis and opportunistic infections)

- Moderate to severe cardiac insufficiency

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
Germany Site Reference ID/Investigator# 35036 Aachen
Germany Site Reference ID/Investigator# 35510 Ahlen
Germany Site Reference ID/Investigator# 35040 Ahrensburg
Germany Site Reference ID/Investigator# 35043 Altenburg
Germany Site Reference ID/Investigator# 35046 Altenholz
Germany Site Reference ID/Investigator# 35049 Amberg
Germany Site Reference ID/Investigator# 35057 Arnstadt
Germany Site Reference ID/Investigator# 35520 Attendorn
Germany Site Reference ID/Investigator# 33349 Augsburg
Germany Site Reference ID/Investigator# 33358 Bad Abbach
Germany Site Reference ID/Investigator# 33361 Bad Abbach
Germany Site Reference ID/Investigator# 35142 Bad Aibling
Germany Site Reference ID/Investigator# 35570 Bad Brambach
Germany Site Reference ID/Investigator# 35573 Bad Bramstedt
Germany Site Reference ID/Investigator# 33372 Bad Endbach
Germany Site Reference ID/Investigator# 33378 Bad Iburg
Germany Site Reference ID/Investigator# 33382 Bad Iburg
Germany Site Reference ID/Investigator# 33387 Bad Kreuznach
Germany Site Reference ID/Investigator# 35575 Bad Kreuznach
Germany Site Reference ID/Investigator# 33391 Bad Liebenwerda
Germany Site Reference ID/Investigator# 33396 Bad Muender
Germany Site Reference ID/Investigator# 102216 Bad Nauheim
Germany Site Reference ID/Investigator# 35578 Bad Neuenahr
Germany Site Reference ID/Investigator# 33404 Bad Rappenau
Germany Site Reference ID/Investigator# 51883 Bad Salzungen
Germany Site Reference ID/Investigator# 33412 Bad Soden-Salmuenster
Germany Site Reference ID/Investigator# 33425 Baden-Baden
Germany Site Reference ID/Investigator# 33429 Bamberg
Germany Site Reference ID/Investigator# 33438 Bautzen
Germany Site Reference ID/Investigator# 33442 Bayreuth
Germany Site Reference ID/Investigator# 33446 Bayreuth
Germany Site Reference ID/Investigator# 33620 Berlin
Germany Site Reference ID/Investigator# 33641 Berlin
Germany Site Reference ID/Investigator# 33648 Berlin
Germany Site Reference ID/Investigator# 33658 Berlin
Germany Site Reference ID/Investigator# 33661 Berlin
Germany Site Reference ID/Investigator# 33670 Berlin
Germany Site Reference ID/Investigator# 33674 Berlin
Germany Site Reference ID/Investigator# 33683 Berlin
Germany Site Reference ID/Investigator# 33687 Berlin
Germany Site Reference ID/Investigator# 33690 Berlin
Germany Site Reference ID/Investigator# 33693 Berlin
Germany Site Reference ID/Investigator# 33697 Berlin
Germany Site Reference ID/Investigator# 33704 Berlin
Germany Site Reference ID/Investigator# 34238 Berlin
Germany Site Reference ID/Investigator# 34246 Berlin
Germany Site Reference ID/Investigator# 34269 Berlin
Germany Site Reference ID/Investigator# 35089 Berlin
Germany Site Reference ID/Investigator# 35527 Berlin
Germany Site Reference ID/Investigator# 35550 Berlin
Germany Site Reference ID/Investigator# 35551 Berlin
Germany Site Reference ID/Investigator# 35597 Berlin
Germany Site Reference ID/Investigator# 34266 Berlin-Buch
Germany Site Reference ID/Investigator# 34252 Berlin-Wannsee
Germany Site Reference ID/Investigator# 35556 Bernau
Germany Site Reference ID/Investigator# 34277 Biberach
Germany Site Reference ID/Investigator# 35562 Binzen
Germany Site Reference ID/Investigator# 34285 Blankenburg/Hart
Germany Site Reference ID/Investigator# 34288 Blaubeuren
Germany Site Reference ID/Investigator# 34291 Bocholt
Germany Site Reference ID/Investigator# 35566 Bocholt
Germany Site Reference ID/Investigator# 35641 Bochum
Germany Site Reference ID/Investigator# 35644 Bogen
Germany Site Reference ID/Investigator# 34296 Bonn
Germany Site Reference ID/Investigator# 34302 Bonn
Germany Site Reference ID/Investigator# 35646 Bonn
Germany Site Reference ID/Investigator# 35652 Bottrop
Germany Site Reference ID/Investigator# 34307 Braunschweig
Germany Site Reference ID/Investigator# 35603 Breitenbrunn
Germany Site Reference ID/Investigator# 35609 Bremen
Germany Site Reference ID/Investigator# 35611 Celle
Germany Site Reference ID/Investigator# 34699 Chemnitz
Germany Site Reference ID/Investigator# 35093 Chemnitz
Germany Site Reference ID/Investigator# 35615 Coesfeld
Germany Site Reference ID/Investigator# 33989 Cologne
Germany Site Reference ID/Investigator# 35237 Cologne
Germany Site Reference ID/Investigator# 34708 Cottbus
Germany Site Reference ID/Investigator# 34711 Cottbus
Germany Site Reference ID/Investigator# 35621 Darmstadt
Germany Site Reference ID/Investigator# 34725 Deggendorf
Germany Site Reference ID/Investigator# 35631 Dessau-Rosslau
Germany Site Reference ID/Investigator# 34742 Dortmund
Germany Site Reference ID/Investigator# 35634 Dortmund
Germany Site Reference ID/Investigator# 35635 Dortmund
Germany Site Reference ID/Investigator# 34748 Dresden
Germany Site Reference ID/Investigator# 34751 Dresden
Germany Site Reference ID/Investigator# 34754 Dresden
Germany Site Reference ID/Investigator# 34760 Dresden
Germany Site Reference ID/Investigator# 35170 Dresden
Germany Site Reference ID/Investigator# 34768 Duesseldorf
Germany Site Reference ID/Investigator# 34773 Duesseldorf
Germany Site Reference ID/Investigator# 34778 Duisburg
Germany Site Reference ID/Investigator# 34784 Eberswalde
Germany Site Reference ID/Investigator# 35184 Elmshorn
Germany Site Reference ID/Investigator# 34809 Erfurt
Germany Site Reference ID/Investigator# 35096 Erfurt
Germany Site Reference ID/Investigator# 35191 Erfurt
Germany Site Reference ID/Investigator# 34821 Erlangen
Germany Site Reference ID/Investigator# 35196 Essen
Germany Site Reference ID/Investigator# 35199 Essen
Germany Site Reference ID/Investigator# 35202 Feldafing
Germany Site Reference ID/Investigator# 35205 Flensburg
Germany Site Reference ID/Investigator# 34833 Forchheim
Germany Site Reference ID/Investigator# 35210 Frankenberg
Germany Site Reference ID/Investigator# 34840 Frankfurt
Germany Site Reference ID/Investigator# 34843 Frankfurt
Germany Site Reference ID/Investigator# 34849 Frankfurt
Germany Site Reference ID/Investigator# 35213 Fraureuth
Germany Site Reference ID/Investigator# 35219 Freiberg
Germany Site Reference ID/Investigator# 34854 Freiburg
Germany Site Reference ID/Investigator# 34861 Freiburg
Germany Site Reference ID/Investigator# 35221 Freiburg
Germany Site Reference ID/Investigator# 35101 Freystadt
Germany Site Reference ID/Investigator# 35224 Friedrichroda
Germany Site Reference ID/Investigator# 34879 Gelsenkirchen
Germany Site Reference ID/Investigator# 34883 Gera
Germany Site Reference ID/Investigator# 34887 Giessen
Germany Site Reference ID/Investigator# 35491 Gosheim
Germany Site Reference ID/Investigator# 34896 Goslar
Germany Site Reference ID/Investigator# 34901 Greifswald
Germany Site Reference ID/Investigator# 34904 Greifswald
Germany Site Reference ID/Investigator# 35496 Greifswald
Germany Site Reference ID/Investigator# 102217 Gross Ammensleben
Germany Site Reference ID/Investigator# 35498 Guben
Germany Site Reference ID/Investigator# 34912 Guestrow
Germany Site Reference ID/Investigator# 35503 Hagen
Germany Site Reference ID/Investigator# 34922 Halle
Germany Site Reference ID/Investigator# 34932 Halle
Germany Site Reference ID/Investigator# 34937 Halle
Germany Site Reference ID/Investigator# 34940 Halle
Germany Site Reference ID/Investigator# 34944 Halle
Germany Site Reference ID/Investigator# 34952 Hamburg
Germany Site Reference ID/Investigator# 34955 Hamburg
Germany Site Reference ID/Investigator# 34958 Hamburg
Germany Site Reference ID/Investigator# 34961 Hamburg
Germany Site Reference ID/Investigator# 34970 Hamburg
Germany Site Reference ID/Investigator# 34974 Hamburg
Germany Site Reference ID/Investigator# 34983 Hamburg
Germany Site Reference ID/Investigator# 34986 Hamburg
Germany Site Reference ID/Investigator# 34994 Hamburg
Germany Site Reference ID/Investigator# 34998 Hamburg
Germany Site Reference ID/Investigator# 35000 Hamburg
Germany Site Reference ID/Investigator# 35007 Hamburg
Germany Site Reference ID/Investigator# 35111 Hamburg
Germany Site Reference ID/Investigator# 35441 Hamburg
Germany Site Reference ID/Investigator# 35444 Hamburg
Germany Site Reference ID/Investigator# 35449 Hamburg
Germany Site Reference ID/Investigator# 35452 Hamburg
Germany Site Reference ID/Investigator# 35019 Hanau
Germany Site Reference ID/Investigator# 33712 Hanover
Germany Site Reference ID/Investigator# 35025 Hanover
Germany Site Reference ID/Investigator# 33792 Harrislee
Germany Site Reference ID/Investigator# 35459 Haseluenne
Germany Site Reference ID/Investigator# 102215 Heidelberg
Germany Site Reference ID/Investigator# 33798 Heidelberg
Germany Site Reference ID/Investigator# 33801 Heidelberg
Germany Site Reference ID/Investigator# 33808 Heidelberg
Germany Site Reference ID/Investigator# 35119 Heidelberg
Germany Site Reference ID/Investigator# 35464 Heidenheim
Germany Site Reference ID/Investigator# 33818 Heilbad Heiligenstadt
Germany Site Reference ID/Investigator# 33825 Herrsching
Germany Site Reference ID/Investigator# 33834 Hof
Germany Site Reference ID/Investigator# 33842 Hofheim
Germany Site Reference ID/Investigator# 33845 Hohenfelde
Germany Site Reference ID/Investigator# 33855 Illertissen
Germany Site Reference ID/Investigator# 33858 Immenstadt
Germany Site Reference ID/Investigator# 35479 Ingolstadt
Germany Site Reference ID/Investigator# 51882 Jena
Germany Site Reference ID/Investigator# 33942 Juelich
Germany Site Reference ID/Investigator# 33946 Kahla
Germany Site Reference ID/Investigator# 35125 Kahla
Germany Site Reference ID/Investigator# 33950 Kaiserslautern
Germany Site Reference ID/Investigator# 33956 Karlsruhe
Germany Site Reference ID/Investigator# 33961 Karlsruhe
Germany Site Reference ID/Investigator# 33964 Kassel
Germany Site Reference ID/Investigator# 34002 Koenigs Wusterhausen
Germany Site Reference ID/Investigator# 34008 Kressbronn
Germany Site Reference ID/Investigator# 34084 Kronach
Germany Site Reference ID/Investigator# 34005 Lahr
Germany Site Reference ID/Investigator# 35245 Landau
Germany Site Reference ID/Investigator# 34100 Leipzig
Germany Site Reference ID/Investigator# 34106 Leipzig
Germany Site Reference ID/Investigator# 34109 Leipzig
Germany Site Reference ID/Investigator# 34112 Leipzig
Germany Site Reference ID/Investigator# 35254 Lippstadt
Germany Site Reference ID/Investigator# 35306 Ludwigsfelde
Germany Site Reference ID/Investigator# 35262 Ludwigshafen
Germany Site Reference ID/Investigator# 34136 Luebeck
Germany Site Reference ID/Investigator# 34139 Lueneburg
Germany Site Reference ID/Investigator# 34147 Magdeburg
Germany Site Reference ID/Investigator# 34150 Magdeburg
Germany Site Reference ID/Investigator# 35276 Mainz
Germany Site Reference ID/Investigator# 34192 Marktredwitz
Germany Site Reference ID/Investigator# 34196 Marl
Germany Site Reference ID/Investigator# 34200 Meissen
Germany Site Reference ID/Investigator# 35285 Menz
Germany Site Reference ID/Investigator# 35287 Minden
Germany Site Reference ID/Investigator# 34208 Mittelherwigsdorf
Germany Site Reference ID/Investigator# 34213 Moenchengladbach
Germany Site Reference ID/Investigator# 34218 Moenchengladbach
Germany Site Reference ID/Investigator# 34221 Moenkeberg
Germany Site Reference ID/Investigator# 34224 Muehlhausen
Germany Site Reference ID/Investigator# 35292 Muelheim
Germany Site Reference ID/Investigator# 34229 Muellheim
Germany Site Reference ID/Investigator# 34048 Muenster
Germany Site Reference ID/Investigator# 34040 Munich
Germany Site Reference ID/Investigator# 34043 Munich
Germany Site Reference ID/Investigator# 34232 Munich
Germany Site Reference ID/Investigator# 34235 Munich
Germany Site Reference ID/Investigator# 35295 Munich
Germany Site Reference ID/Investigator# 35298 Munich
Germany Site Reference ID/Investigator# 34052 Naunhof
Germany Site Reference ID/Investigator# 34061 Neubrandenburg
Germany Site Reference ID/Investigator# 34064 Neuburg
Germany Site Reference ID/Investigator# 34071 Neumuenster
Germany Site Reference ID/Investigator# 35313 Neuss
Germany Site Reference ID/Investigator# 34076 Neustadt
Germany Site Reference ID/Investigator# 35321 Niederbrombach
Germany Site Reference ID/Investigator# 34080 Niefern-Oeschelbronn
Germany Site Reference ID/Investigator# 34158 Nienburg
Germany Site Reference ID/Investigator# 34173 Oelsnitz
Germany Site Reference ID/Investigator# 34176 Offenburg
Germany Site Reference ID/Investigator# 33492 Oldenburg
Germany Site Reference ID/Investigator# 34718 Ostseebad Damp
Germany Site Reference ID/Investigator# 35335 Paderborn
Germany Site Reference ID/Investigator# 33508 Parchim
Germany Site Reference ID/Investigator# 35340 Passau
Germany Site Reference ID/Investigator# 33517 Pfullendorf
Germany Site Reference ID/Investigator# 67482 Pirna
Germany Site Reference ID/Investigator# 33523 Planegg
Germany Site Reference ID/Investigator# 33528 Plauen
Germany Site Reference ID/Investigator# 33466 Potsdam
Germany Site Reference ID/Investigator# 33470 Potsdam
Germany Site Reference ID/Investigator# 33476 Pruem
Germany Site Reference ID/Investigator# 33479 Puettlingen
Germany Site Reference ID/Investigator# 33484 Radebeul
Germany Site Reference ID/Investigator# 35347 Radebeul
Germany Site Reference ID/Investigator# 35136 Ratingen
Germany Site Reference ID/Investigator# 33488 Ratzeburg
Germany Site Reference ID/Investigator# 33883 Regensburg
Germany Site Reference ID/Investigator# 33886 Regensburg
Germany Site Reference ID/Investigator# 33890 Regensburg
Germany Site Reference ID/Investigator# 33897 Reken
Germany Site Reference ID/Investigator# 33902 Rendsburg
Germany Site Reference ID/Investigator# 33907 Rheine
Germany Site Reference ID/Investigator# 35355 Rickenbach
Germany Site Reference ID/Investigator# 33911 Riesa
Germany Site Reference ID/Investigator# 33914 Rinteln
Germany Site Reference ID/Investigator# 33923 Rostock
Germany Site Reference ID/Investigator# 33927 Rostock
Germany Site Reference ID/Investigator# 33931 Rothenburg
Germany Site Reference ID/Investigator# 35362 Ruedersdorf
Germany Site Reference ID/Investigator# 34016 Saarbruecken
Germany Site Reference ID/Investigator# 34023 Salzwedel
Germany Site Reference ID/Investigator# 34027 Sande
Germany Site Reference ID/Investigator# 33534 Schneeberg
Germany Site Reference ID/Investigator# 33539 Schramberg
Germany Site Reference ID/Investigator# 33542 Schutterwald
Germany Site Reference ID/Investigator# 35371 Schwandorf
Germany Site Reference ID/Investigator# 33549 Schwerin
Germany Site Reference ID/Investigator# 35376 Schwerin
Germany Site Reference ID/Investigator# 33555 Schwerte
Germany Site Reference ID/Investigator# 33559 Seesen
Germany Site Reference ID/Investigator# 33563 Senden
Germany Site Reference ID/Investigator# 35380 Singen
Germany Site Reference ID/Investigator# 33567 Sinsheim
Germany Site Reference ID/Investigator# 33572 Soltau
Germany Site Reference ID/Investigator# 33577 Spremberg
Germany Site Reference ID/Investigator# 35383 St. Martin
Germany Site Reference ID/Investigator# 33588 Stadthagen
Germany Site Reference ID/Investigator# 33592 Steinhagen
Germany Site Reference ID/Investigator# 33598 Stuttgart
Germany Site Reference ID/Investigator# 33604 Stuttgart
Germany Site Reference ID/Investigator# 33607 Stuttgart
Germany Site Reference ID/Investigator# 33611 Stuttgart
Germany Site Reference ID/Investigator# 35389 Suhl
Germany Site Reference ID/Investigator# 35391 Tegernau
Germany Site Reference ID/Investigator# 33625 Torgelow
Germany Site Reference ID/Investigator# 33637 Ueberlingen-Nussdorf
Germany Site Reference ID/Investigator# 35395 Uffenheim
Germany Site Reference ID/Investigator# 33721 Ulm
Germany Site Reference ID/Investigator# 33724 Ulm
Germany Site Reference ID/Investigator# 33734 Viersen
Germany Site Reference ID/Investigator# 33737 Villingen-Schwenningen
Germany Site Reference ID/Investigator# 35397 Voehringen
Germany Site Reference ID/Investigator# 33742 Waltrop
Germany Site Reference ID/Investigator# 33749 Weener
Germany Site Reference ID/Investigator# 33751 Weissenfels
Germany Site Reference ID/Investigator# 33852 Welzow
Germany Site Reference ID/Investigator# 35404 Wiefelstede
Germany Site Reference ID/Investigator# 33761 Wiesbaden
Germany Site Reference ID/Investigator# 33765 Wiesbaden
Germany Site Reference ID/Investigator# 35408 Wiesbaden
Germany Site Reference ID/Investigator# 35413 Wiesbaden
Germany Site Reference ID/Investigator# 33772 Wilhelmshaven
Germany Site Reference ID/Investigator# 33780 Wittlich
Germany Site Reference ID/Investigator# 33718 Wuerzburg
Germany Site Reference ID/Investigator# 35420 Wuppertal
Germany Site Reference ID/Investigator# 33864 Zerbst
Germany Site Reference ID/Investigator# 33867 Zeven
Germany Site Reference ID/Investigator# 33873 Zwickau
Germany Site Reference ID/Investigator# 33876 Zwickau
Germany Site Reference ID/Investigator# 33880 Zwiesel

Sponsors (1)

Lead Sponsor Collaborator
AbbVie (prior sponsor, Abbott)

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change From Baseline in Disease Activity Score (DAS) 28 The Disease Activity Score 28 is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, the erythrocyte sedimentation rate (ESR), and the patient's assessment of global disease activity (on a visual analog scale [VAS] from 0 to 10 cm) are included in the DAS28 score. If the ESR value is missing, the C-reactive protein (CRP) value can be substituted. Scores on the DAS28 range from 0 to 10; higher scores indicate more disease activity. A DAS28 score >5.1 indicates high disease activity, a DAS28 score <3.2 indicates low disease activity, and a DAS28 score <2.6 indicates clinical remission. Baseline and Months 3, 6, 9, 12, 18, and 24 No
Primary Percentage of Participants in DAS28 Remission Clinical remission is defined as a disease activity score (DAS) 28 score of < 2.6. The DAS28 is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, the erythrocyte sedimentation rate (ESR), and the patient's assessment of global disease activity (assessed on a visual analog scale [VAS] from 0 to 10 cm) are included in the DAS28. If the ESR value is missing, the C-reactive protein (CRP) value can be substituted. Scores on the DAS28 range from 0 to 10; higher scores indicate more disease activity. Months 3, 6, 9, 12, 18, and 24 No
Secondary Percentage of Participants With a Significant Therapeutic Response Significant therapeutic response was determined by DAS28 critical difference (Dcrit). A Dcrit response is a statistically determined value that exceeds the threshold of random fluctuation and signifies a positive individual response during treatment. A DAS28-Dcrit individual therapeutic response is defined as a decrease (improvement) in DAS28 from Baseline of = 1.8.
The DAS28 is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, the erythrocyte sedimentation rate (ESR), and the patient's assessment of global disease activity (assessed on a visual analog scale [VAS] from 0 to 10 cm) are included in the DAS28. If the ESR value is missing, the C-reactive protein (CRP) value can be substituted. Scores on the DAS28 range from 0 to 10; higher scores indicate more disease activity.
Baseline and Months 3, 6, 9, 12, 18, and 24 No
Secondary Percentage of Participants With Low, Moderate and High Disease Activity The DAS28 is a validated index of rheumatoid arthritis disease activity. Twenty-eight tender joint counts, 28 swollen joint counts, the erythrocyte sedimentation rate (ESR), and the patient's assessment of global disease activity (assessed on a visual analog scale [VAS] from 0 to 10 cm) are included in the DAS28. If the ESR value is missing, the C-reactive protein (CRP) value can be substituted. Scores on the DAS28 range from 0 to 10; higher scores indicate more disease activity.
Low disease activity is defined as a DAS28 score = 3.2; Moderate disease activity as a DAS28 >3.2 to =5.1; High disease activity as a DAS28 >5.1.
Baseline and Months 3, 6, 9, 12, 18, and 24 No
Secondary Erythrocyte Sedimentation Rate (ESR) Over Time Erythrocyte sedimentation rate (ESR) indirectly measures how much inflammation is in the body. A higher ESR is indicative of increased inflammation. Baseline and Months 3, 6, 9, 12, 18, and 24 No
Secondary C-Reactive Protein (CRP) Levels Over Time C-Reactive Protein (CRP) was measured from blood samples as a marker for inflammation. Higher levels are indicative of more inflammation. Normal concentration in healthy human serum is usually lower than 10 mg/L, slightly increasing with age. Baseline and Months 3, 6, 9, 12, 18, and 24 No
Secondary Tender Joint Count (TJC) Over Time Twenty-eight joints were assessed and classified as tender/not tender by pressure and joint manipulation on physical examination. Baseline and Months 3, 6, 9, 12, 18, and 24 No
Secondary Swollen Joint Count (SJC) Over Time Twenty-eight joints were assessed and classified as swollen/not swollen by pressure and joint manipulation on physical examination. Baseline and Months 3, 6, 9, 12, 18, and 24 No
Secondary Hannover Functional Questionnaire (FFbH) Over Time A self-administered patient questionnaire used to assess patient function based on 18 questions. The numerically coded responses to the questions are added to provide a total patient score. The FFbH was calculated from this patient score by the following formula:
FFbH = (patient score x 100) รท 2 (number of valid responses). The resulting FFbH score reflects the degree of remaining functional capacity where 0 indicates maximal impairment and 100 indicates maximal functional capacity.
Baseline and Months 3, 6, 9, 12, 18, and 24 No
Secondary Patients Global Assessment of Disease Activity Over Time Participants indicated their global assessment of disease activity over the last 7 days on a visual analog scale (VAS) from 0 (best) to 10 (worst) cm; lower scores indicate better patient status. Baseline and Months 3, 6, 9, 12, 18 and 24 No
Secondary Participants Assessment of Fatigue Over Time Participants indicated their level of fatigue over the last 7 days on a visual analog scale (VAS) from 0 (best) to 10 (worst) cm; lower scores indicate better patient status. Baseline and Month 3, 6, 9, 12, 18, and 24 No
Secondary Participants Assessment of Pain Over Time Participants indicated their level of pain over the last 7 days on a visual analog scale (VAS) from 0 (best) to 10 (worst) cm; lower scores indicate better patient status. Baseline and Months 3, 6, 9, 12, 18, and 24 No
Secondary Percentage of Participants With Impairment in Daily Activities Participants were asked to report how many days of impairment in daily activities they had experienced in the last 4 weeks. Baseline and Months 3, 6, 9, 18, and 24 No
Secondary Number of Days Missed From Work Due to Rheumatoid Arthritis Participants reported the number of days they had missed from work in the prior 6 months. The Baseline measurement includes data for the prior 12 months. Baseline and Months 6, 12, 18, and 24 No
Secondary Percentage of Participants With In-patient Hospitalization The percentage of participants with in-patient hospitalization in the prior 6 months. Baseline data includes in-patient hospitalizations that occurred within the prior 12 months. Month 6, 12, 18, and 24 No
Secondary Percentage of Participants on Concomitant Rheumatoid Arthritis and Pain Relief/Anti-inflammatory Medication Baseline and Months 3, 6, 9, 12, 18, and 24 No
See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Completed NCT04171414 - A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid Arthritis Phase 3
Completed NCT02833350 - Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Phase 2
Completed NCT04255134 - Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN) Phase 4
Recruiting NCT05615246 - Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)
Completed NCT03248518 - Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases N/A
Completed NCT03514355 - MBSR in Rheumatoid Arthritis Patients With Controlled Disease But Persistent Depressive Symptoms N/A
Recruiting NCT06005220 - SBD121, a Synbiotic Medical Food for RA Management N/A
Recruiting NCT05451615 - Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis Phase 3
Completed NCT05054920 - Eccentric Versus Concentric Exercises for Rotator Cuff Tendinopathy in Patients With Rheumatoid Arthritis N/A
Completed NCT02037737 - Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting N/A
Recruiting NCT04079374 - Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Phase 3
Completed NCT02504268 - Effects of Abatacept in Patients With Early Rheumatoid Arthritis Phase 3
Recruiting NCT05496855 - Remote Care in People With Rheumatoid Arthritis N/A
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Recruiting NCT06103773 - A Study of Single and Multiple Oral Doses of TollB-001 Phase 1
Recruiting NCT06031415 - Study of GS-0272 in Participants With Rheumatoid Arthritis Phase 1
Completed NCT05999266 - The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Recruiting NCT04169100 - Novel Form of Acquired Long QT Syndrome Phase 4

External Links